Journal Watch · Frontiers in Immunology · 2026
The dual role of T cells in solid organ transplant rejection and immune tolerance.
This article systematically reviews the molecular mechanisms of T cell-mediated rejection, functional heterogeneity among T cell subsets, and their differential impacts on various types of solid organ transplants.
TL;DR
This article systematically reviews the molecular mechanisms of T cell-mediated rejection, functional heterogeneity among T cell subsets, and their differential impacts on various types of solid organ transplants.
Key findings
- This article systematically reviews the molecular mechanisms of T cell-mediated rejection, functional heterogeneity among T cell subsets, and their differential impacts on various types of solid organ transplants.
What they did
As the central effector cells of adaptive immunity, T cells drive acute rejection by directly recognizing donor alloantigens (such as MHC molecules) or indirectly recognizing processed donor antigens presented by antigen-presenting cells. Recent studies have revealed the dual roles of distinct T cell subsets in rejection or tolerance: pro-inflammatory Th1, Th2, Th17, and CD8<sup>+</sup> cytotoxic T cells(CTLs) exacerbate tissue damage by secreting cytokines such as IFN-γ and IL-17, whereas regulatory T cells(Tregs) promote graft tolerance by suppressing effector T cell activation and maintaining immune homeostasis.
Full abstract (original)
Background: Solid organ transplantation, a major breakthrough in modern medicine, has saved countless patients with end-stage organ failure. However, immune rejection remains the primary obstacle to transplant success.
What they did: As the central effector cells of adaptive immunity, T cells drive acute rejection by directly recognizing donor alloantigens (such as MHC molecules) or indirectly recognizing processed donor antigens presented by antigen-presenting cells. Recent studies have revealed the dual roles of distinct T cell subsets in rejection or tolerance: pro-inflammatory Th1, Th2, Th17, and CD8<sup>+</sup> cytotoxic T cells(CTLs) exacerbate tissue damage by secreting cytokines such as IFN-γ and IL-17, whereas regulatory T cells(Tregs) promote graft tolerance by suppressing effector T cell activation and maintaining immune homeostasis.
Results & conclusions: This article systematically reviews the molecular mechanisms of T cell-mediated rejection, functional heterogeneity among T cell subsets, and their differential impacts on various types of solid organ transplants.
Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1787579 · PubMed 41972181.
Why it matters for pharma & biotech
- Relevant to Immunology teams tracking Frontiers in Immunology for new targets, mechanisms and biomarkers.
- Because it reports human data, it can inform indication, endpoint and comparator decisions faster than preclinical work.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- As a review, this paper synthesises prior studies rather than reporting new experimental data; weight it accordingly.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Frontiers in Immunology study find?
This article systematically reviews the molecular mechanisms of T cell-mediated rejection, functional heterogeneity among T cell subsets, and their differential impacts on various types of solid organ transplants.
What type of study is this?
It is a review / perspective, published in Frontiers in Immunology in 2026. As the central effector cells of adaptive immunity, T cells drive acute rejection by directly recognizing donor alloantigens (such as MHC molecules) or indirectly recognizing processed donor antigens presented by antigen-presenting cells.
Where can I read the original paper?
The original is at the publisher via DOI 10.3389/fimmu.2026.1787579. PubMed ID: 41972181. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/the-dual-role-of-t-cells-in-solid-organ-transplant-rejection-and-immune-787579/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides